Upcoming events
Seminarium: Sverige – världsbäst på innovation, men hur bra är vi på implementering?
Life City SwedenBio-evenemang
Träffa din nästa samarbetspartner på Nordic Life Science Days
We welcome everyone working in life science - biotechnology, pharmaceuticals, medical technology, diagnostics and e-health - to the largest partnering conference in the Nordic region. During the meeting, in addition to private meetings with business partners through the internationally recognized partnering platform, a solid stage program is offered. Of course, as a member you have a discount!
"At the SwedenBIO Executive Dinner I met Peter Gaskin of Charles River Labs who led our expansion into Switzerland"
Anna Fahlgren, CEO of Bioreperia, which develops zebrafish models in Linköping.
SwedenBIO driving the creation of a new hub for Nordic life science to invest internationally.
Together with regional and Nordic cooperation organizations, we want to create a hub with the task of advancing the positions of Nordic life science in an international perspective. The goal is to increase the number of collaborations, both commercial and academic, while supporting the development of SwedenBIO's member companies on the world market.
Business & Finance
How to create sustainable trading on the stock market
The life science sector is one of the strongest for listed small companies in Sweden. At the same time, competition in the sector is fierce and it is necessary to work on issues related to share trading. Well-functioning share trading is important for creating growth in small and medium-sized companies.
Offer to you as an incubator company
Life for start-up companies was not without challenges before the effects of the corona crisis hit and the situation is now tough for many smaller companies. Now we want to help build Sweden's next generation of life science companies strong, for future export revenues and innovation power. Start-up companies with up to four employees can be members of SwedenBIO for an annual fee of SEK 1000.
What is the future of dual listings in the US? When is it the right time? These are the questions Adam Kostyal tries to answer in the latest episode of Brännpunkt Life Science.
Brännpunkt Life Science is an interview series in collaboration with DNB Sweden that focuses on the intersection between innovation, capital and health. In the first part, we meet Adam Kostyal, European Head of Listing at Nasdaq, who looks at what the stock market year looked like for the sector, talks about the impact of the pandemic and shares his predictions for the future.
